These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cost-effectiveness of Simvastatin plus Ezetimibe for Cardiovascular Prevention in CKD: Results of the Study of Heart and Renal Protection (SHARP). Mihaylova B, Schlackow I, Herrington W, Lozano-Kühne J, Kent S, Emberson J, Reith C, Haynes R, Cass A, Craig J, Gray A, Collins R, Landray MJ, Baigent C, SHARP Collaborative Group. Am J Kidney Dis; 2016 Apr; 67(4):576-84. PubMed ID: 26597925 [Abstract] [Full Text] [Related]
25. IMPROVE-IT: what have we learned? Banach M, Nikolic D, Rizzo M, Toth PP. Curr Opin Cardiol; 2016 Jul; 31(4):426-33. PubMed ID: 27218683 [Abstract] [Full Text] [Related]
27. Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study). Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM. J Clin Lipidol; 2011 Jul; 5(6):474-82. PubMed ID: 22108151 [Abstract] [Full Text] [Related]
28. Effects of ezetimibe/simvastatin on lipoprotein subfractions in patients with primary hypercholesterolemia: an exploratory analysis of archived samples using two commercially available techniques. Ose L, Reyes R, Johnson-Levonas AO, Sapre A, Tribble DL, Musliner T. Clin Ther; 2007 Nov; 29(11):2419-32. PubMed ID: 18158082 [Abstract] [Full Text] [Related]
29. Ezetimibe and recent clinical trials: a look on the bright side. Ahmed MH. Expert Opin Drug Saf; 2010 Jul; 9(4):511-4. PubMed ID: 20377476 [Abstract] [Full Text] [Related]
31. Ezetimibe plus simvastatin for the treatment of hypercholesterolemia. Gryn SE, Hegele RA. Expert Opin Pharmacother; 2015 Jun; 16(8):1255-62. PubMed ID: 25920750 [Abstract] [Full Text] [Related]
32. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin. Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E, Ezetimibe Study Group. Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231 [Abstract] [Full Text] [Related]
33. Combination therapy with ezetimibe and simvastatin to achieve aggressive LDL reduction. Robinson JG, Davidson MH. Expert Rev Cardiovasc Ther; 2006 Jul; 4(4):461-76. PubMed ID: 16918265 [Abstract] [Full Text] [Related]
36. Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels. Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D. Am J Cardiol; 2007 Jun 15; 99(12):1706-1713. PubMed ID: 17560879 [Abstract] [Full Text] [Related]
37. Effect of co-administering ezetimibe with on-going simvastatin treatment on LDL-C goal attainment in hypercholesterolemic patients with coronary heart disease. Farnier M, Volpe M, Massaad R, Davies MJ, Allen C. Int J Cardiol; 2005 Jul 10; 102(2):327-32. PubMed ID: 15982505 [Abstract] [Full Text] [Related]